The study, DFC-002, included 353 patients with moderate-to-severe postsurgical pain who were randomized to receive one of five dose levels of Dyloject(TM) ranging up to 75 mg, IV Ketorolac tromethamine
30 mg, or placebo.
now Roche Palo Alto), or any other person is engaging in unfair competition by monopolizing or attempting to monopolize the market for ketorolac tromethamine
ophthalmic solution by preventing or slowing generic competition to ACULAR(R) (ketorolac tromethamine
ophthalmic solution 0.
Contract awarded for Provision of Ketorolac Tromethamine
30 Mg/1ml Isp Reg No: F-18727/11 More Than Two Years Due, Delivery Time 24 To 48 Hours
ACULAR LS(TM) is a new, optimized formulation of ketorolac tromethamine
and joins this family of products used for a range of other conditions including post-surgical inflammation, pain, photophobia and ocular itch associated with seasonal allergies.
This launch is the first part of an alliance in which Taylor and Baxter will jointly develop, manufacture and market four injectable products with current sales in excess of $200 million: Ketorolac Tromethamine
Injection, Amrinone Lactate Injection, Diltiazem HCl Injection and Labetalol HCl Injection.
Nasdaq:TEVIY) announced today it has received tentative approval from the Food and Drug Administration (FDA) to manufacture and market Ketorolac Tromethamine
All patients in the LRP received parenteral ketorolac tromethamine
, a nonsteroidal anti-inflammatory drug: ability to inhibit post-radical pelvic surgery adhesions in a porcine model.
A double-blind evaluation of ketorolac tromethamine
versus acetaminophen in pediatric tonsillectomy: Analgesia and bleeding.
is widely used in gynecologic and other forms of surgery but has been contraindicated in labor, delivery, and postpartum care over concern that it could adversely affect fetal circulation and inhibit uterine contractions.